Article: Psoriasis unresponsive to topical corticosteroids improvised with high concentration tacalcitol ointment.(Washington Whispers)(Author Abstract)

In this prospective, multicenter, open-label non-controlled study, the use of high concentration (20[micro]g/g) tacalcitol ointment was tested in psoriasis that had previously been unresponsive to topical corticosteroids. Tacalcitol is one of the active vitamin D3 analogs. Conventional preparations of tacalcitol currently available include 2 [micro]g/g of ointment, cream, and scalp solution in Japan, and 4 [micro]g/g of ointment in European countries. However, the 20 [micro]g/g dose is still currently in clinical trials.

The study cohort included 82 patients in 31 hospitals in Japan. Patients with psoriatic lesions that had shown low or no response to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!